Deficiency of the Cytoskeletal Protein SPECC1L Leads to Oblique Facial Clefting  by Saadi, Irfan et al.
ARTICLE
Deficiency of the Cytoskeletal Protein SPECC1L
Leads to Oblique Facial Clefting
Irfan Saadi,1,11,12 Fowzan S. Alkuraya,1,11,13 Stephen S. Gisselbrecht,1 Wolfram Goessling,1
Resy Cavallesco,1 Annick Turbe-Doan,1 Aline L. Petrin,2 James Harris,3 Ursela Siddiqui,1
Arthur W. Grix, Jr.,4 Hanne D. Hove,5 Philippe Leboulch,1,6 Thomas W. Glover,7
Cynthia C. Morton,8,14 Antonio Richieri-Costa,9 Jeffrey C. Murray,2 Robert P. Erickson,10
and Richard L. Maas1,*
Genetic mutations responsible for oblique facial clefts (ObFC), a unique class of facial malformations, are largely unknown. We
show that loss-of-function mutations in SPECC1L are pathogenic for this human developmental disorder and that SPECC1L is a
critical organizer of vertebrate facial morphogenesis. During murine embryogenesis, Specc1l is expressed in cell populations of the devel-
oping facial primordial, which proliferate and fuse to form the face. In zebrafish, knockdown of a SPECC1L homolog produces a face-
less phenotype with loss of jaw and facial structures, and knockdown in Drosophila phenocopies mutants in the integrin signaling
pathway that exhibit cell-migration and -adhesion defects. Furthermore, in mammalian cells, SPECC1L colocalizes with both tubulin
and actin, and its deficiency results in defective actin-cytoskeleton reorganization, as well as abnormal cell adhesion and migration.
Collectively, these data demonstrate that SPECC1L functions in actin-cytoskeleton reorganization and is required for proper facial
morphogenesis.Introduction
Orofacial clefts are a common congenital facial defect that
affect on average one in 800 live births.1 Cleft lip with or
without cleft palate (CL/P) comprises themajority of orofa-
cial clefts, and a number of contributory genes, including
several from recent genome wide association studies,2
have been identified.1 In contrast, having been definitively
described by Tessier in 1976,3 oblique facial clefts (ObFCs)
represent a rare form of orofacial clefts (0.25% of the total),
for which the genetic basis is largely unknown. In fact, it
has even been postulated that ObFCs occur only from
mechanical tearing and not from primary defects in facial
morphogenesis.4
Facial morphogenesis requires coordinated morphoge-
neticmovements in the threedimensionsof thedeveloping
facial prominences and the precise control of basic cellular
processes, including cell proliferation, differentiation, mi-
gration, and adhesion. Membranous bones of the head
and facial skeleton, as well as cartilage, dental pulp, adipo-
cytes, dermis, and some connective tissue, derive from
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patterning of the mesoderm-derived facial musculature is
regulated by the CNC during facial development.6 During
the fourthweek of gestation, CNCmigrates from the dorsal
neural tube into the branchial arches and facial region
to comprise the ectomesenchyme of the facial promi-
nences.5 Although the cellular basis for ObFC remains
unclear, it is attractive to hypothesize that a failure of
CNCmigration, proliferationormaxillary (MxP) and lateral
nasal prominence (LNP) fusion could be responsible.
CNC migration commences with the epithelial-mesen-
chymal transition and delamination of ectomesenchymal
neural crest (NC) cells from the neural folds, and it in-
volves their movement along paths dictated by anatomical
constraints, the local extracellular matrix (ECM), and
differentiation cues.5 Mechanistically, this migration has
both intrinsic and extrinsic components. Intrinsic compo-
nents include the ability of CNC cells to reorganize their
cytoskeleton in response to their environment and thus
alter cell shape and motility. The migratory behavior of
NC cells is initiated and maintained by several signaling
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ephrinB, neuregulin, and endothelin molecules (reviewed
in Nelms and Labosky7). The extrinsic component, which
includes the ECM composition and the physical environ-
ment throughwhich the CNCmigrates, provides the direc-
tional cues to the integrin-bearing CNC cell as it moves
from the neural tube toward the branchial arches.5–7 The
growth of the branchial arches then gives rise to the facial
prominences, which eventually fuse to form the face.
The analysis of balanced chromosomal rearrangements
that are linked to human facial dysmorphoses such as
ObFC offers an unbiased approach to identifying genes
that are required for proper formation of the human face.
Here, we report identification of SPECC1L mutations in
two patients with ObFC. SPECC1L is a previously unchar-
acterized gene predicted to encode a coiled-coil domain
(CCD) containing protein. Our cellular analyses show
that SPECC1L is a ‘‘cross-linking’’ protein that functionally
interacts with both microtubules and with the actin cyto-
skeleton. Furthermore, SPECC1L knockdown analysis in
zebrafish, Drosophila, and mammalian cells shows a role
for SPECC1L in cell migration and adhesion, downstream
of the integrin, Ca2þ and non-canonical Wnt signaling
pathways, each of which engenders reorganization of the
actin cytoskeleton. Collectively, these data provide a
genetic basis for ObFC and implicate defective SPECC1L-
mediated cell migration and adhesion as a potential under-
lying mechanism.Material and Methods
ObFC Patients and Controls
DGAP177 was previously described8 with a balanced translocation
between chromosomes 1 and 22, [46,XX,t(1;22)(q21;q12)], which
has been revised herein to [46,XX,t(1;22)(q21.3;q11.23)]. This
white female from the U.S. exhibited bilateral oromedial-canthal
(Tessier IV) clefts, and a head CTscan revealed normal brain paren-
chyma but severe bilateral ocular hypoplasia. DGAP177 also had
a unilateral calcaneovarus foot deformity. Twenty-three other
patients with ObFC were also ascertained: seven from Brazil, 12
from the Philippines, three from the U.S., and one from Denmark.
The two sequence variants identified in two different male Bra-
zilian patients are NM_015330.2 (SPECC1L_v001) c.569C>T
(p.Thr190Met) and c.1244A>C (p.Gln415Pro). DNA samples
from 258 population-matched Brazilian and 50 North American
normal individuals were used as controls. Parental DNA samples
were obtained for the Brazilian patients with the two missense
changes (p.Thr190Met and p.Gln415Pro). The identity of the
parental samples to the patient harboring the de novo
c.1244A>Cmutation was confirmed with a panel of microsatellite
markers from theCombinedDNA Index System (CODIS) database.Cytogenetics
Peripheral blood specimens were collected with institutional-
review-board-approved informed consent for the Developmental
Genome Anatomy Project (DGAP) through the Partner’s Health-
care System, as well as through the Universidade de Sao˜ Paulo
(Brazil), the University of Iowa, and Rigshospitalet (Copenhagen,
Denmark). Cell transformation aimed at generating DGAP177Thelymphoblastoid cells was performed via standard protocols.9
Metaphase preparations from the cell lines were used in all fluores-
cence in situ hybridization (FISH) experiments. Probes were
derived from bacterial artificial chromosomes (BACs), fosmids, or
long-range PCR products. Probes mapping to the region of the
cytogenetically determined breakpoints were selected from the
University of California Santa Cruz Human Genome Browser.
Probe DNA was labeled by nick translation with SpectrumGreen
or SpectrumOrange (Abbott, Abbott Park, IL), denatured, and
hybridized to chromosomal preparations fixed to microscope
slides.9 At least ten metaphases were scored per hybridization.
Comparative genome hybridization (CGH) microarray analysis
was performed with the Spectral Genomics (Houston, TX) 1 Mb
BAC array.
Reverse-Transcriptase Polymerase Chain Reaction
Total RNA was extracted from DGAP177 lymphoblasts with the
RNeasy Mini Kit (QIAGEN, Germantown, MD), and cDNA was
synthesized with the iScript cDNA Synthesis Kit (Bio-Rad,
Hercules, CA). This cDNAwas subsequently used for conventional
polymerase chain reaction (PCR) as well as quantitative reverse-
transcriptase PCR (qRT-PCR) for SPECC1L transcripts with the iQ
SYBR Green Supermix (Bio-Rad, Hercules, CA) on an iQ Light-
Cycler (Bio-Rad, Hercules, CA). Primers used resided in exons 8
and 14 (see Table S1 available online).
In Situ Hybridization
Whole-mount and section in situ experiments were performed
with two different probes for Specc1l. Primers that incorporated
either SP6 or T7 promoter sequence upstream of the gene-specific
sequences were used for amplification of the cDNA products that
were subsequently used as templates for riboprobe generation
via in vitro transcription coupled with UTP-digoxigenin labeling.
All primer sequences are provided in Table S1.
Zebrafish Husbandry and Morpholino Knockdown
Zebrafish were maintained according to protocols of the institu-
tional animal care and use committee. Morpholinos (MOs) (Gene-
Tools, Philomath, OR) designed against the ATG and exon 1 splice
sites of Specc1l-chr5, Specc1l-chr8, and Specc1l-chr21 (Table S1)were
injected into one-cell-stage embryos.
Drosophila Knockdown
The Drosophila conditional RNAi fly for the SPECC1L ortholog,
CG13366, was obtained from the Vienna Drosophila Resource
Center (stock #108092). The stock is from the RNAi library gener-
ated by insertion of the antisense sequence via phiC integrase.10
The conditional fly was crossed with the daughterless-GAL4 strain
(Bloomington stock #5460) for a ubiquitous knockdown and with
A9-GAL4 (Bloomington stock #8761) for a wing-imaginal-disc-
specific knockdown.
Cloning and Mutagenesis
Full-length and C-terminal calponin homology domain (CHD)
truncated cDNA (designated DCHD) of Specc1l (NM_153406)
were cloned into a Gateway pENTR/SD/D-TOPO vector (Invitro-
gen, Carlsbad, CA) and transferred to a Gateway-compatible
destination vector with a C-terminal GFP tag (pcDNA-DEST47,
Invitrogen, Carlsbad, CA). p.Thr190Met and p.Gln415Pro muta-
tions were created with the QuikChange Mutagenesis kit (Strata-
gene, La Jolla, CA) according to the manufacturer’s protocol.American Journal of Human Genetics 89, 44–55, July 15, 2011 45
The cDNA fragment encoding amino acids 887–997 of SPECC1L
was cloned into the pGEX6p-2 vector to create a GST-tagged
peptide that was then used to generate a rabbit polyclonal anti-
body (Covance, Princeton, NJ). The specificity of the SPECC1L
antibody was confirmed in two different experiments: (1) overex-
pressed Specc1l-GFP was specifically detected by the antibody, and
(2) immunoblotting of SPECC1L-knockdown cell lysate showed
a decrease in a protein band of the expected size of approximately
120 kDa (see Supplemental Data).
Cell Culture
DGAP177 lymphoblastoid cells were grown in RPMI 1640 media
(GIBCO-Invitrogen, Carlsbad, CA) supplemented with 10% FBS.
Human 293T kidney epithelial and U2OS osteosarcoma cells
(kindly provided by the late Dr. Priscilla A. Schaffer, University
of Arizona) were cultured in standard DMEM supplemented with
10% FBS. Cell transfections were carried out in 24-well plates
with Superfect (QIAGEN, Germantown, MD) reagent according
to the manufacturer’s protocol. Immunostaining was carried out
on coverslips coated with poly-L-lysine. In brief, cells were fixed
in 4% PFA for 10 min, followed by blocking in PBS with 1% goat
serum and 0.1% Tween. SPECC1L and g-tubulin antibodies were
used at a 1:4000 dilution, and remaining antibodies were used at
a 1:1000 dilution. F-actin staining was carried out with rhoda-
mine-labeled phalloidin (Cytoskeleton Inc., Denver, CO), diluted
1:500 in PBS, for 30 min. After staining, coverslips were mounted
in VectaShield containing DAPI (Vector Labs, Burlingame, CA).
Nocodazole treatment aimed at reducing the microtubule-associ-
ated background was carried out as described.11
Lentiviral Knockdown
Two lentiviral preparations, each containing a different short
hairpin, V2LHS_41578 (B8) or TRCN0000112962 (C1) against
human SPECC1L (Open Biosystems, Huntsville, AL), were used
for transduction of 293T and U2OS cells. A lentiviral preparation
containing a short hairpin against GFP was used as a control. In
brief, 1.5 3 106 cells seeded onto a 10 cm dish were transduced
with ~5 3 105 TU of lentiviral supernatant in the presence of
8 mg/ml polybrene for 6 hr at 37C. Transduced cells were then
selected by culture in 3 mg/ml puromycin for approximately two
weeks. Upon confluence, cells were plated at very low densities
(~1:5000 dilution) so that clonal cell lines would be created. Single
colonies were isolated with sterile cloning disks (Thermo Fisher
Scientific, Waltham, MA) and expanded.
Wound-Repair, or Scratch, Assay
U2OS wild-type and SPECC1L-kd cells (5 3 105) were plated in a
6-well plate and grown to confluence. Cells were then scratched
with a pipette tip, and themedia were replaced. Images were taken
at pre-marked locations after defined periods of time. For Wnt
treatments, we used conditioned media obtained from cells over-
expressing Wnt5a or Wnt3a (ATCC, Washington, D.C.) to treat
cells for 30 min after scratch treatment.12 Cells were then fixed
and stained as described above.Results
Identification of SPECC1LMutations in ObFC Patients
We ascertained a white female (DGAP177) with the
previously reported apparently balanced chromosomal46 The American Journal of Human Genetics 89, 44–55, July 15, 2011translocation 46,XX,t(1;22)(q21;q12). She was born with
bilateral, symmetrical ObFC (oromedial-canthal, Tessier
IV) and also exhibited microphthalmia, cleft palate, and
talipes calcaneovarus deformity.8 FISH analyses with
probes generated from BAC and fosmid clones showed
that the 1q21 breakpoint region (chr1:149,713,417–
149,752,534, identified with the March 2006 NCBI36/
hg18 assembly), identified from a split signal with fosmid
G248P84603E5, does not span any known genes. In
contrast, the breakpoint on 22q, reassigned as 22q11.23
after FISH analyses, was identified from a split signal
with fosmid G248P81272C11, which spans the 30-region
of SPECC1L (chr22:22,996,866–23,143,221) and part of
the downstream gene, ADORA2A (chr22:23,121,123–
23,158,636) (Figures 1A and 1B). The breakpoint region
was refined to exclude ADORA2A by Southern blot analysis
with probes generated from the proximal end of the split
fosmid G248P81272C11. Aberrant bands in DGAP177
DNA after AvaII, PstI, and SacI digestion narrowed the
breakpoint to a 5 kb region in intron 14 of the calponin
homology and coiled-coil-domain-containing gene,
SPECC1L (chr22:23,122,059–23,128,018) (Figure 1B).
Comparative genomic hybridization (CGH) microarray
analysis at an average 1 Mb genome-wide resolution did
not reveal any copy-number variants (CNVs) of clinical
significance. Because of the proximity of SPECC1L to
genomic regions for DiGeorge (DGS [MIM 188400]), Veloc-
ardiofacial (VCFS [MIM 192430]), and distal 22q11.2 dele-
tion (MIM 611867) syndromes, we performed a detailed
literature search and did not find any reported cases of
deletions that extended into SPECC1L.13 Using the Data-
base of Genomic Variants and DECIPHER, we found two
reports of small duplications14,15 and one instance of
a small deletion15 in normal samples. This deletion encom-
passed only exon 2 of SPECC1L (Variation_32455). Inter-
estingly, exon 2 of SPECC1L encodes only a part of the 50
UTR and is shown to be spliced variably in the RefSeq
database.
We confirmed SPECC1L haploinsufficiency at the RNA
level in DGAP177 lymphoblastoid cells by using conven-
tional and quantitative real-time RT-PCR (Figures 1C and
1D). In situ hybridization in embryonic day 9.5–10.5
(E9.5–E10.5) mouse embryos showed Specc1l expression
in the developing maxillary prominence (MxP) and the
lateral nasal process (LNP), which fail to fuse in ObFC, as
well as in the limbs and eye (Figure 1E; see also Figure S1).
To establish further involvement of SPECC1L in the
pathogenesis of ObFC, we sequenced its coding region in
23 ObFC patients, including seven from Brazil, 12 from
the Philippines, one from Denmark, and three from the
U.S. The sequencing analysis identified heterozygous
missense changes, c.569C>T (p.Thr190Met) and
c.1244A>C (p.Gln415Pro), in two Brazilian male patients
with Tessier IV clefting. These variants, p.Thr190Met and
p.Gln415Pro, occur, respectively, in the first and second of
three predicted CCDs of SPECC1L (Figure 1F). Parental
samples were subsequently obtained and sequenced for
Figure 1. SPECC1L Disruption and Muta-
tion in ObFC Patients
(A and B) FISH analysis of metaphase chro-
mosomes from DGAP177 lymphoblasts
and schematic of fosmid G248P81272C11
spanning the 22q breakpoint, which dis-
rupts SPECC1L in a 5 kb region of intron 14.
(C and D) RT-PCR and qRT-PCR show
haploinsufficiency of SPECC1L transcripts
(arrow; relative to ACTB transcripts, arrow-
head) in RNA from DGAP177 and control
lymphoblasts.
(E) Whole-mount in situ hybridization
shows Specc1l expression in maxillary and
lateral nasal prominences (bracket), eyes
(arrow), and limbs (arrowhead) at E9.5.
(F) SPECC1L representation showing the
positionof thep.Thr190Metpolymorphism
and p.Gln415Pro missense mutation. CCD,
coiled coil domain; CHD, calponin
homology domain.
(G) Tessier IV type cleft in the patient with
the p.Gln415Pro mutation.both cases. The p.Thr190Met change was found in the clin-
ically unaffected maternal sample and was thus assigned
as a likely nonfunctional polymorphism. However, the
p.Gln415Pro change was not detected in either unaffected
parent and therefore arose de novo. The p.Gln415Pro
variant was also not present in 258 population-matched
Brazilian controls (516 chromosomes), in 50 North Amer-
ican controls, or in any of the SNP databases. Moreover,
p.Gln415Pro is predicted by PolyPhen, SIFT, and pMUT
mutation evaluation algorithms16 to have a deleterious
effect on protein function. The patient with the
p.Gln415Promutation has severe unilateral Tessier IV cleft-
ing on the right and mild Tessier VII clefting on the left,
normal eyes, and no other birth defects (Figure 1G).
Knockdown of a Zebrafish SPECC1L Homolog Results
in Loss of Facial Structures
To obtain further evidence of a role for SPECC1L in verte-
brate facial morphogenesis, we performed a morpholino
(MO)-based knockdown of the three previously uncharac-The American Journal of Huterized SPECC1L homologs in zebra-
fish; these homologs are located on
fish chromosomes 5, 8, and 21 (Fig-
ure S2). Knockdown of the zebrafish
chromosome 5 homolog specifically
resulted in a ‘‘faceless’’ phenotype
characterized by a MO-dose-depen-
dent loss of jaw and facial structures,
whereas knockdown of either of the
other two homologs alone did not
produce an observable phenotype
evenat thehighestMOconcentration
tested (Figures 2A–2F andnot shown).
Skeletal components of the verte-
brate jaw and face derive from CNCthat migrates to the first and second branchial
arches.17,18 In zebrafish, the first mandibular arch gives
rise to Meckel’s (M) and palatoquadrate (PQ) cartilages
that form the lower and upper jaws, respectively. The
second hyoid arch, in contrast, gives rise to cartilages
that support the jaw, including ceratohyal (CH) and
hyosymplectic (HS) cartilages.18 In our faceless morphant,
at low concentrations of the chromosome 5 MO, both
Meckel’s and ceratohyal cartilages were reduced in size.
However, at high concentrations, all facial cartilage was
absent and only a small remnant of the hyosymplectic
cartilage remained (Figure 2F). We also examined NC
migration in the zebrafish by using crestin as a marker. As
expected from the facial cartilage defects, NC migration
into the branchial arches was significantly impaired. At
more posterior embryonic levels, crestin expression was
also reduced, but the underlying pattern of NC migration
was retained (Figures 2A0–2E0). These data suggest a func-
tion for SPECC1L in facial development across at least
two vertebrate classes, mammals and fish.man Genetics 89, 44–55, July 15, 2011 47
Figure 2. Specc1l Knockdown Results in Zebrafish ‘‘Faceless’’ and Drosophila ‘‘Split Discs’’ Phenotypes
(A–E and A0–E0) Lateral views of 120 hpf fish stained with alcian blue for cartilage (A–E) and of 24 hpf fish stained for crestin (A0–E0),
a neural crest (NC) marker, after morpholino (MO) treatment. Control (A and A0) and chromosome-8-homolog (C8) MO at the highest
dose (B and B0) appear normal. In contrast, increasing doses of the zebrafish chromosome-5-homolog (C5) MO results in diminishing
sizes of facial structures (C–E; arrows and brackets) and poor NC migration to the anterior branchial arches (C0–E0; arrows).
(F) Schematic representation of the effect on jaw cartilages after MO treatment. M, Meckel’s; PQ, palatoquadrate; CH, ceratohyal; HS,
hyosymplectic; *, missing cartilage.
(G–P) The Drosophila SPECC1L-ortholog (CG13366) conditional RNAi line (108092) was crossed with da-GAL4 and A9-GAL4 flies
for ubiquitous (G–J) or wing-imaginal-disc-specific (K–P) knockdown. Resulting flies were flightless with inflated (G and H), crumpled
(K and L), or blistered (M and N) wings. Eclosing flies with ubiquitous knockdown failed to survive, probably as a result of feeding
problems from the defective proboscis (I and J). Some flies with severely affected wings also showed a mild cleft dorsum (O and P).Knockdown of a SPECC1L Ortholog in Drosophila
Phenocopies Integrin Signaling Mutants
To identify molecular pathways perturbed by SPECC1L
deficiency, we knocked down the previously uncharacter-
ized Drosophila ortholog of SPECC1L, CG13366, by using
an inducible RNA hairpin10 driven by the ubiquitous
daughterless-Gal4 driver. A small number of severely
affected flies failed to eclose and died as pharate adults.
Eclosing flies were infertile and flightless and had a range
of wing defects, including inflated, crumpled, or blistered
wings (Figures 2G and 2H). These flies died 2–3 days after
eclosion as a result of distal proboscis defects (Figures 2I48 The American Journal of Human Genetics 89, 44–55, July 15, 2011and 2J) and feeding difficulties. Using a A9-Gal4 driver,
we also knocked down CG13366 specifically in wing imag-
inal discs. All resulting flies were flightless; approximately
70% had partially or completely uninflated, crumpled
wings (Figures 2K and 2L), and the remaining 30% ex-
hibited wings that were ‘‘held out’’ and had blisters (Figures
2M and 2N). Among flies with uninflated, crumpled wings,
70% also had a mild cleft dorsum (Figures 2O and 2P).
The Drosophila wing blade forms when two layers of
cells derived from the dorsal and ventral regions of the
wing imaginal disc migrate, appose, and subsequently
adhere via integrin-mediated cell adhesion. Indeed, the
Figure 3. Specc1l-GFP Stabilizes Acety-
lated a-Tubulin-Containing Microtubules
(A) GFP-tagged Specc1l (green) in U2OS
cells stabilizes a subset of microtubules
(arrows) stained with b-tubulin (red).
(B) The stabilized subset colocalizes with
acetylated a-tubulin-containing microtu-
bules (yellow, arrows).
(C) Specc1l-GFP distorts the actin cyto-
skeleton (red) and cell shape (arrow).
(D–F) In contrast to wild-type Specc1l-
GFP (A and D) and Thr190Met-GFP (E),
which show no apparent difference in
microtubule stabilization, a C-terminal
truncation (DCHD) completely abolishes
stabilization (F).
(G) Notably, the Gln415Pro-GFP mutant
significantly reduces stabilization of acety-
lated a-tubulin-containing microtubules.
Scale bars represent 10 mm.completely penetrant wing phenotypes in CG13366-
knockdown flies strikingly phenocopy Drosophila mutants
that are known to affect the integrin signaling pathway;
such mutants include inflated (integrin aPS2), multiple
edematous wings (integrin aPS1), wing blister (laminin
a1,2), and blistery (tensin) (reviewed in references19–21).
Together with the zebrafish and mouse data, these results
suggest a role for SPECCIL in integrin-mediated migration
and adhesive interactions of cell populations in the devel-
oping human facial prominences.The American Journal of HuSpecc1l-GFP Expression Stabilizes
Microtubules
We extended our functional analysis
by expressing a GFP-tagged mSpecc1l
in U2OS osteosarcoma cells. Expres-
sion of Specc1l-GFP stabilized a subset
of microtubules, as detected by en-
hanced b-tubulin immunostaining,
and this effect was prevented by
pretreatment with the microtubule-
depolymerizing agent nocodazole
(Figure 3A; see also Figure S3A). Im-
munostaining also showed that
the Specc1l-stabilized microtubules
contained acetylated a-tubulin (Fig-
ure 3B), a known component of
stabilized microtubules.22 Because
Specc1l contains a C-terminal CHD
that in other contexts can facilitate
actin binding,23 we also examined
actin staining. Specc1l-GFP expres-
sion severely altered the cellular actin
cytoskeleton and the overall cell
shape (Figure 3C). Next, we tested
whether the Specc1l Thr190Met-GFP
and Gln415Pro-GFP variants also
stabilized acetylated a-tubulin-con-
taining microtubules. Consistentwith the view that c.569C > T represents a neutral poly-
morphism, Thr190Met-GFP expression produced no
visible effect. In contrast, expression of a truncated form
of Specc1l lacking the CHD (DCHD-GFP) nearly abolished
formation of stabilized microtubules, suggesting that
Specc1l stabilizes microtubules via an interaction with
the actin cytoskeleton (Figures 3D–3F). Strikingly,
Gln415Pro-GFP expression severely impaired formation
of stabilized acetylated-a-tubulin-containing microtu-
bules, although not to the same degree as DCHD-GFP,man Genetics 89, 44–55, July 15, 2011 49
Figure 4. SPECC1L Colocalizes with
Tubulin and Actin
(A and B) Endogenous SPECC1L shows a
microtubule-type cytoplasmic expression
pattern (arrows); a site of intranuclear ex-
pression is also detected (arrowheads; also
see [E] below).
(C and D) SPECC1L colocalizes with acety-
lated a-tubulin (yellow and orange) in the
mitotic spindle during cytokinesis (C) and
in gap junctions (D).
(E and F) Punctate expression of SPECC1L
is seen in the presumptive microtubule-
organizing center (MTOC) surrounding
centrioles stained with g-tubulin.
(G and H) Colocalization with F-actin (G,
arrows) is better visualized after nocoda-
zole treatment (H, arrows).
(I) After ionomycin treatment, SPECC1L
relocates with F-actin to the cell mem-
brane. Scale bars represent 10 mm.supporting the view that this variant constitutes a patho-
logic mutation (Figure 3G).
Cellular SPECC1L Colocalizes with Microtubules
and the Actin Cytoskeleton
We generated an antibody to SPECC1L (Figure S2B) to
determine its cellular expression. As predicted by Specc1l-
GFP expression, endogenous SPECC1L in U2OS cells
showed a microtubule-type cytoplasmic expression pat-
tern (Figures 4A and 4B; arrows). We also coimmuno-
stained U2OS cells for SPECC1L and for acetylated
a-tubulin. Indeed, SPECC1L localization overlapped with
that of acetylated a-tubulin in the mitotic spindles during
cell division and in gap junctions, which are involved in
cell adhesion24 (Figures 4C and 4D). SPECC1L also showed50 The American Journal of Human Genetics 89, 44–55, July 15, 2011punctate expression (Figures 4A and
4B; arrowheads) that localized in a
ring around g-tubulin-labeled centri-
oles in the presumptive microtubule-
organizing center (MTOC) (Figures
4E and 4F). Such a pattern suggests
association with the negative ends of
spindle microtubules and a role in
spindle orientation and cell polarity,
both critical factors in directional
migration.25
Given that SPECC1L contains a
CHD that facilitates actin binding23
and that Specc1l overexpression
distorts the actin cytoskeleton (Fig-
ure 3C), we asked whether SPECC1L
also localizes to the actin cytoskel-
eton. First, we pretreated U2OS cells
with nocodazole to minimize expres-
sion from microtubule-associated
SPECC1L. Thismanipulation revealed
a filamentous pattern of SPECC1L,which partly colocalized with phalloidin-stained F-actin
fibers (Figures 4G and 4H). Second, to assess whether the
actin cytoskeletal association was functional, we treated
the cells with ionomycin, which increases intracellular
calcium and rapidly reorganizes the actin cytoskeleton,
with F-actin fibers translocating to the cell membrane. Ion-
omycin treatment produced a concomitant translocation
of SPECC1L to the cell membrane (Figure 4I), suggesting
a role in actin-cytoskeleton reorganization. These cellular
localization studies implicate SPECC1L as a novel ‘‘cross-
linking’’ protein that interacts both with microtubules
and with the actin cytoskeleton.26 Moreover, taken
together with the zebrafish and Drosophila data, the find-
ings suggest that SPECC1L function in actin-cytoskeleton
reorganization is necessary for cell adhesion andmigration.
Figure 5. Cell-Adhesion Defects in
SPECC1L-Deficient Cells
(A–C) EBV-transformed control lympho-
blasts show increased integrin LFA-1-
dependent adhesion in culture and grow
as large circular clumps (A). DGAP177
EBV-transformed lymphoblasts fail to
form these large clumps (B) and show
reduced levels of integrin aL (ITGAL) tran-
scripts (C). Data represent average tran-
script level 5 standard error of the mean
from three independent experiments.
(D and E) The adhesion defect is accompa-
nied by altered F-actin staining and
reduced numbers of F-actin microspikes
(arrows) when SPECCIL-deficient cells are
compared to control cells.
(F–I) Similar to control cells (F), SPECC1L-
knockdown (SPECC1L-kd) 293T clonal
cells (G) adhere normally to the culture
plate at low density on day 2. Upon reach-
ing confluence at day 5, control cells
continue to adhere to the culture plate
(H), whereas knockdown cells fail to
adhere and lift off the plate (I).
(J–M) Plating SPECC1L-kd cells onMatrigel
does not prevent this loss of adhesion at
confluency on day 5.
(N and O) Compared with control cells
(N), SPECC1L-kd 293T cells show ab-
normal F-actin staining (O) with reduced
numbers of microspikes (arrows). Scale
bars represent 10 mm.Knockdown of SPECC1L in Mammalian Cells Results
in Cell-Adhesion and -Migration Defects
To test this hypothesis further, we analyzed DGAP177 lym-
phoblastoid cells and RNAi-based SPECC1L-knockdown
clonal lines established from 293T and U2OS cells
(Figure S4). First, we noted that DGAP177 lymphoblastoid
cells failed to form the large clumps that characterize
Epstein-Barr virus (EBV)-transformed cells27 (Figures 5A
and 5B). EBV transformation causes increased adhesion
as a result of upregulation of integrin LFA-1 (leukocyte
function antigen-1), which consists of integrins aL
(ITGAL) and b2 (ITGB2).27 Indeed, consistent with a defect
in integrin-based cell adhesion, ITGAL expression was
reduced by more than 2-fold (p < 0.03) in DGAP177 cells
compared with control lymphoblastoid cells (Figure 5C).
Second, we observed that although 293T SPECC1L-knock-
down (SPECC1L-kd) cells attached well to culture plates
when initially seeded (Figures 5F and 5G), they failed—in
contrast to control cells—to remain adherent upon reach-
ing confluency (Figures 5H and 5I). To test whether this
adhesion failure was due to a defect in extracellular matrixThe American Journal of Hu(ECM) production or to an inability of
the cells to bind ECM, we plated the
cells on Matrigel, which contains all
major ECM substrates. 293T knock-
down cells initially attached (Figures
5J and 5K) but, in contrast to control
cells, failed to remain adherent uponconfluency (Figures 5L and 5M). Lastly, analysis of actin
staining both in DGAP177 patient lymphoblastoid cells
and in 293T knockdown cells showed reduced numbers
of F-actin microspikes and filopodia (Figures 5D, 5E, 5N,
and 5O); reductions in each have been linked to reduced
cell adhesion and motility.28,29
To test the direct involvement of SPECC1L in cell migra-
tion, we examined the ability of two independent
SPECC1L-kd clonal U2OS cell lines to migrate and seal
acellular gaps in a wound-repair protocol. SPECC1L-kd
U2OS-knockdown cells (uB8-5, uB8-9) showed a reduced
ability to close such gaps (Figure 6A); moreover, in the
knockdown cells the central actin fibers were more promi-
nent and were randomly organized (Figures 6B and 6C). To
show that SPECC1L deficiency results in a functional
defect in actin cytoskeleton reorganization, we treated
wild-type and knockdown cells with either ionomycin or
Wnt5a, both known to reorganize the actin cytoskeleton.
In response to ionomycin, knockdown cells failed to reor-
ganize the actin fibers rapidly to the cell membrane (Fig-
ures 6D and 6E). We treated cells with the noncanonicalman Genetics 89, 44–55, July 15, 2011 51
Figure 6. Migration and Actin-Cytoskeleton-Reorganization
Defects in SPECC1L-Knockdown Cells
(A) Wound-repair (scratch) assays were used in comparisons of the
ability of SPECC1L-kd U2OS clonal cells (uB8-5, uB8-9) versus
control knockdown cells (uGFPi) to migrate. In severe cases,
knockdown cells fail to close the wound (arrows) even after 23 hr.
(B and C) F-actin staining of SPECC1L-kd cells shows an increase
in actin fibers in the center of the cells (overlying the nuclei)
when these cells are compared to control cells (arrows).
(D and E) Ionomycin treatment causes rapid reorganization of the
actin cytoskeleton to the cell membrane in control cells, whereas
SPECC1L-kd cells respond poorly (arrows).
(F and G) Wound-repair assays with control and knockdown cells
were treated with the noncanonical Wnt ligand, Wnt5a. In
control cells, Wnt5a reorganizes the actin cytoskeleton toward
the leading edge, perpendicular to the direction of migration (F).
In contrast, knockdown cells show an abnormal alignment of
actin fibers (G), indicating defective ability to reorganize the actin
52 The American Journal of Human Genetics 89, 44–55, July 15, 2011Wnt ligand Wnt5a in wound-repair assays to induce direc-
tional cell migration. In response to Wnt5a, control cells
reorganized the actin cytoskeleton such that actin fibers
aligned perpendicularly to the direction of migration12
(compare Figures 6F and 6H). In contrast, actin fibers in
SPECC1L-kd cells failed to orient perpendicular to the
direction of migration, indicating an inability to properly
reorganize the actin cytoskeleton (Figure 6G). As a further
control, Wnt3a, a canonical Wnt ligand that does not
induce actin-cytoskeletal reorganization, produced no
effect on control cells or on knockdown cells, which
continued to show markedly concentrated central actin
fibers (compare Figures 6H and 6I with Figures 6B and 6C).Discussion
Our data identify mutations in SPECC1L as contributory to
the pathogenesis of ObFC. The evidence includes: (1) an
intron 14 disruption of SPECC1L in DGAP177 and a func-
tionally defective de novo SPECC1L missense variant,
p.Gln415Pro, both associated with ObFC; (2) expression
in developing murine facial prominences, and (3) a loss
of facial structures in a zebrafish knockdown model. These
data do not, however, rule out the possibility that variants
in other genes might also contribute to ObFC.
SPECC1L encodes a novel cytoskeletal cross-linking
protein. Interactions between microtubules and actin-
cytoskeleton filaments are critical in many mechanical
cellular processes, including cell movement, cell division,
and wound healing. In response to stimuli, these processes
require the rapid dynamic assembly of polarized cytoskel-
etal polymers of actin and tubulin to form higher-order
structures such as radial arrays or bundles. Examples of
these structures include the bipolar microtubular spindles
that form during cell division and the actin-mediated
protrusions located at the leading edge of migrating
cells.30–33
Experiments in which Specc1l-GFP was overexpressed
suggest a role for SPECC1L in microtubule stability and
in actin cytoskeleton organization. In addition, the endog-
enous cellular expression of SPECC1L further indicates its
presence in mitotic spindles and in the MTOC. In partic-
ular, the punctate pattern of SPECC1L expression around
the centrioles suggests that SPECC1L might be associated
with the negative ends of spindle microtubules and
thereby be involved in spindle orientation and cell
polarity, both critical for directional cell migration. These
results place SPECC1L in a distinct functional class of
cross-linking proteins that include adenomatous polyposiscytoskeleton. Dotted lines indicate alignment of actin filaments;
arrows indicate the direction of migration.
(H and I) The canonical Wnt ligand, Wnt3a, which does not reor-
ganize the actin cytoskeleton in control cells (H) (note similarity to
[B]), was used as a control. Knockdown cells continue to show
markedly concentrated central actin fibers (I, arrows) (note simi-
larity to [C]). Scale bars represent 10 mm.
coli (APC),34,35 cytoplasmic dynein/dynactin,36 and
MACF,37 each of which affects both spindle orientation
and microtubule stability.
SPECC1L knockdown inmammalian cells demonstrated
a profound impairment in the ability of cells to reorganize
the actin cytoskeleton rapidly in response to stimuli such
as Ca2þ and Wnt5a. The noncanonical Wnt5a/Ca2þ
pathway induces actin cytoskeletal reorganization and
plays a vital role in the polarized cell migratorymovements
that form the vertebrate body.38 In fact, Wnt5a/ null
mice lack structures that protrude out of the primary
body axis, including the face and limbs.39 Combined
with Specc1l expression in the developing MxP and LNP,
this suggests a role for SPECC1L in mediating the effect
of various stimuli that act during facial morphogenesis
and require reorganization of the actin cytoskeleton.
Indeed, the knockdown-induced deficiency of the
SPECC1L homolog in zebrafish and of the ortholog in
Drosophila results in migration and adhesion defects that
can be reconciled with the pathogenesis of human ObFC.
The wing defects observed after SPECC1L ortholog knock-
down in Drosophila strongly phenocopy known mutants of
the integrin signaling pathway. These known integrin-
pathway fly mutants also frequently manifest the cleft
dorsum phenotype evident in some of our mutant flies.40
Whereas the wing blister phenotype results from a lack of
cell adhesion, the cleft dorsum reflects a cell-migration
defect whereby cells derived from the two wing imaginal
discs fail to migrate properly and fuse. These migration and
adhesion defects are thought to lead to improper flight-
muscle attachment at the dorsum and thereby result in the
flightless phenotype observed in mild alleles of integrin
signaling mutants.20 Furthermore, pharate arrest combined
with dorsum, proboscis, and feeding defects have been re-
ported in Mnn-overexpressing flies with reduced Jun/JNK
activity downstream of integrin signaling.41 Thus, almost
all of the Drosophila CG13366 mutant phenotypes can be
attributed to a failure of migration or adhesion of opposing
imaginal-disc-derived cells, and we have accordingly given
CG13366 the name split discs.
The zebrafish faceless phenotype is similar to that of
the chinless mutant that lacks CNC-derived cartilage and
mesoderm-derived muscles.42 Although the chinless gene
remains unidentified, two genes known to play minor
roles in zebrafish jaw development are integrina543 and
endothelin1.44 Mutants for both genes show missing or
severely reduced ventral jaw cartilages (CH, HS), which
are also lost in our faceless morphant. Future analyses of
SPECC1L function will be required to elucidate whether
our faceless phenotype results from a failure of CNC to
properly migrate and populate the facial prominences or
from an abnormal signaling environment within the
prominences after they are populated by CNC. It is also
important to note that although a facial phenotype was
observed with the zebrafish chromosome 5 SPECC1L-
homolog knockdown, the chromosome 8 and 21 homo-
logs are actually more similar to SPECC1L and might beThemore functionally related. It will be of interest to deter-
mine the phenotypes resulting from combinatorial knock-
downs of chromosome 5, 8, and 21 homologs of SPECC1L.
Together, the zebrafish and Drosophila mutants imply
that SPECC1L might mediate endothelin and integrin
signaling. The endothelin pathway leads to an intracellular
increase in calcium, which affects cell shape and
motility.45,46 Because SPECC1L-kd U2OS cells fail to reor-
ganize the actin cytoskeleton properly after ionomycin-
induced intracellular calcium increase, it is plausible that
they could be impaired in responding to endothelin
signaling as well. Integrins comprise a superfamily of
cell-adhesion receptors that bind ECM or cell-surface
ligands. Upon ligand binding, integrins can transduce a
signal into the cell (via ‘‘outside-in signaling’’); they can
also receive intracellular signals that regulate their ligand-
binding affinity (via ‘‘inside-out signaling’’).20 A defect in
integrin-mediated signaling is consistent with our observa-
tions that DGAP177 lymphoblasts fail to form integrin-
dependent clusters and that upon reaching confluence,
SPECC1L-kd 293T cells fail to bind to ECM.
Lastly, we have identified one disruption and one
missense mutation in SPECC1L in two individuals with
ObFC. The p.Gln415Pro amino acid change was not pre-
sent in 258 population-matched or in 50 CEPH controls,
nor in any of the extant SNP databases, and we have
used an overexpression system to show that the
p.Gln415Pro change causes a functional defect in microtu-
bule stabilization. Our results thus provide a genetic basis
for ObFC and demonstrate that ObFC can result from
mutations in SPECC1L, which most likely regulates cell
migration and adhesion in cells that comprise the devel-
oping facial prominences.Supplemental Data
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